Literature DB >> 19710584

Predictors of the duration of the respiratory syncytial virus season.

Philip Zachariah1, Sohum Shah, Dexiang Gao, Eric A F Simões.   

Abstract

BACKGROUND: Data from national surveillance shows significant regional variation in the respiratory syncytial virus (RSV) season. To enable accurate recommendations for surveillance and prophylaxis at a local level, we examined this variation in detail and determined predictors for the duration of the RSV season.
METHODS: Statewide hospitalization data for the years (1996-2006) were summarized by postal zip code and linked to the corresponding Colorado Zip Code Tabulation Area (ZCTA). Demographic data from the 2000 Census and geographic variables created using geographic information systems were merged with hospitalization data, using the ZCTA as the common unit of analysis. Univariate and multivariate logistic regression analysis were used to determine predictors of the duration of the RSV season in a ZCTA.
RESULTS: A 2-year quasi periodic (biennial) pattern was seen for RSV hospitalizations in Colorado. Significant variability was observed for the duration of the RSV season between ZCTA's and within the same ZCTA during 10 seasons. ZCTA's with longer season lengths tended to be urban crowded with larger families, with a higher proportion of children less than 5 years and Hispanics. The number of children younger than 5 years per room and per square km, and the urban/rural character of a ZCTA were found in logistic regression to be significant predictors of season length (P < 0.05).
CONCLUSIONS: Demographic factors influence the duration of the RSV season. Indices of overcrowding and population density as well as being urban or rural can be used to stratify the duration of the RSV season, establish targeted surveillance, and tailor prophylaxis in an area.

Entities:  

Mesh:

Year:  2009        PMID: 19710584     DOI: 10.1097/INF.0b013e3181a3e5b6

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

1.  Reduced-Dose Schedule of Prophylaxis Based on Local Data Provides Near-Optimal Protection Against Respiratory Syncytial Virus.

Authors:  Daniel M Weinberger; Joshua L Warren; Claudia A Steiner; Vivek Charu; Cécile Viboud; Virginia E Pitzer
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

2.  Respiratory syncytial virus-associated hospitalizations in pre-mature infants in Lima, Peru.

Authors:  Theresa J Ochoa; Rossana Bautista; Carmen Dávila; José Antonio Salazar; Carlos Bazán; Oscar Guerra; Jean Pierre Llanos; Luis López; Alonso Zea-Vera; Lucie Ecker
Journal:  Am J Trop Med Hyg       Date:  2014-10-06       Impact factor: 2.345

3.  Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection.

Authors:  Alexander Gutfraind; Alison P Galvani; Lauren Ancel Meyers
Journal:  JAMA Pediatr       Date:  2015-04       Impact factor: 16.193

4.  Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection.

Authors:  Oludare A Odumade; Simon D van Haren; Asimenia Angelidou
Journal:  Clin Infect Dis       Date:  2022-08-15       Impact factor: 20.999

5.  Respiratory syncytial virus--United States, July 2012-June 2014.

Authors:  Amber K Haynes; Mila M Prill; Marika K Iwane; Susan I Gerber
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-12-05       Impact factor: 17.586

6.  Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States.

Authors:  Virginia E Pitzer; Cécile Viboud; Wladimir J Alonso; Tanya Wilcox; C Jessica Metcalf; Claudia A Steiner; Amber K Haynes; Bryan T Grenfell
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

7.  Viral Etiology of acute respiratory tract infections in hospitalized children and adults in Shandong Province, China.

Authors:  Ti Liu; Zhong Li; Shengyang Zhang; Shaoxia Song; Wu Julong; Yi Lin; Nongjian Guo; Chunyan Xing; Aiqiang Xu; Zhenqiang Bi; Xianjun Wang
Journal:  Virol J       Date:  2015-10-14       Impact factor: 4.099

8.  Challenges to evaluating respiratory syncytial virus mortality in Bangladesh, 2004-2008.

Authors:  Lauren J Stockman; W Abdullah Brooks; Peter K Streatfield; Mustafizur Rahman; Doli Goswami; Kamrun Nahar; Mohammed Z Rahman; Stephen P Luby; Larry J Anderson
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.

Authors:  Christopher S Ambrose; Evan J Anderson; Eric A F Simões; Xionghua Wu; Hanaa Elhefni; C Lucy Park; Frangiscos Sifakis; Jessie R Groothuis
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

10.  Respiratory syncytial virus activity--United States, July 2011-January 2013.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-01       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.